Subject: Forbes Recognizes PharmCo Rx for its Expertise in CBD Products

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
Forbes Recognizes PharmCo Rx for its Expertise in CBD Products
Hot Stock to WatchHot Stock to Watch

Company: Progressive Care Inc. (OTCQB: RXMD)


Last:

Price: 0.054

Change (%): + 0.004 (8.00)

Volume: 448,602
RXMD Chart

Forbes Recognizes PharmCo Rx for its Expertise in CBD Products

MIAMI, Aug. 16, 2019 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered media coverage in Forbes in an article titled, It’s national CBD Day: Have You Tried These Products? by Jeanne Croteau.

“PharmCo recently began providing CBD as an alternative or additional therapy for our patients,” said S. Parikh Mars, CEO of Progressive Care Inc. “We specialize in fighting opioid dependency and abuse through creating custom compounds and providing personalized medication therapy management for our patients. We believe that our knowledge and expertise in CBD is beneficial to patients exploring their treatment options and we want to provide our patients with the best products on the market for their individual needs.”

In the article published August 8, 2019 in Forbes titled, It’s National CBD Day: Have You Tried These Products? Forbes writer, Jeanne Croteau mentions “a growing number of professional athletes are using CBD for pain relief and recovery. To meet this growing demand PharmCo Rx, a Florida-based company, has become the first [independent] pharmacy to offer CBD tinctures and capsules.”

“We are proud to be recognized by Forbes as a trusted source for CBD products,” Ms. Mars continued. “We have done extensive research into CBD and its benefits and risks to patients. We believe that a well-qualified pharmacy is the best place to get CBD therapy information and products with verified ingredients.”

Continue Reading


IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks